Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inter-observer reliability of the HERDOO2 clinical decision rule.
Gauthier K, Le Gal G, Shivakumar S, Anderson D, Chagnon I, Solymoss S, Ortel T, Yeo E, Kearon C, Rodger M. Gauthier K, et al. Among authors: solymoss s. Thromb Res. 2016 May;141:136-8. doi: 10.1016/j.thromres.2016.03.015. Epub 2016 Mar 15. Thromb Res. 2016. PMID: 27031923 No abstract available.
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Kearon C, et al. Among authors: solymoss s. N Engl J Med. 2003 Aug 14;349(7):631-9. doi: 10.1056/NEJMoa035422. N Engl J Med. 2003. PMID: 12917299 Free article. Clinical Trial.
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
Kearon C, Julian JA, Kovacs MJ, Anderson DR, Wells P, Mackinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M, Ginsberg JS; ELATE Investigators. Kearon C, et al. Among authors: solymoss s. Blood. 2008 Dec 1;112(12):4432-6. doi: 10.1182/blood-2008-06-163279. Epub 2008 Sep 12. Blood. 2008. PMID: 18791166 Free article. Clinical Trial.
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
Gándara E, Kovacs MJ, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, Solymoss S, Crowther M, Carrier M, Langlois N, Kovacs J, Little Ma J, Carson N, Ramsay T, Rodger MA. Gándara E, et al. Among authors: solymoss s. Thromb Haemost. 2013 Dec;110(6):1172-9. doi: 10.1160/TH13-06-0488. Epub 2013 Sep 26. Thromb Haemost. 2013. PMID: 24067945
102 results